[多药耐药性麻醉症] 这种麻醉症
A M González-García1, M Morán-Sánchez2, A R Sánchez-Serrano1
1Hospital Universitario de Salamanca, Salamanca, España.
Revista de neurologia
|July 21, 2023
概括
1型麻醉症是一种罕见的神经系统疾病,治疗可能具有挑战性. 皮托利桑特为1型麻醉症患者提供了一个有前途的治疗选择,改善了症状并减少了其他药物的副作用.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 神经科学是一个神经科学.
背景情况:
- 麻醉症1型是一种罕见的慢性神经系统疾病,其特点是下丘脑中产生素的神经元的损失.
- 主要症状包括过度的白天嗜睡,触发症,睡眠和幻觉,显著影响患者的生活质量.
- 虽然存在各种治疗方法,但一些患者仍然对传统疗法不耐药.
研究的目的:
- 报告一例1型麻醉症的病例,成功用皮托利桑坦治疗.
- 评估皮托利桑特在患有耐治疗性1型麻醉症的患者的疗效和耐受性.
- 突出向胰岛素激素系统用于麻醉症管理的潜力.
主要方法:
- 一名被诊断为1型麻醉症的43岁男性接受了多种药物治疗,包括抗抑郁药,神经刺激药和氧酸盐.
- 患者经历了不充分的症状控制和之前治疗的显著副作用.
- 皮托利桑被引入作为辅助疗法,并对其对症状和副作用的影响进行了监测.
主要成果:
- 引入皮托利桑导致了患者1型麻醉症症状的显著改善,包括过度的白天嗜睡和触感.
- 同时,还可以降低之前处方的药物的剂量.
- 患者报告说,与他们之前的药物治疗方案相关的不良反应的严重程度和频率有所降低.
结论:
- 皮托利桑特在控制1型麻醉症症状方面表现出显著的疗效,特别是在对其他治疗有抗性的病例中.
- 通过皮托利桑特调节基因组系统,为1型麻醉症提供了一种有价值的治疗策略.
- 这一案例强调了皮托利桑特在改善患者的治疗结果和减少1型麻醉症管理中的副作用负担方面的潜力.
相关概念视频
Narcolepsy
145
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
145
Sleep-Wake Cycles
1.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.4K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
202
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
202
Management of Insomnia
281
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
281
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
91
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
91
Substance Use Disorders Affecting Sleep
198
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
198


